These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 11371684)

  • 1. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
    Carr A; Miller J; Eisman JA; Cooper DA
    AIDS; 2001 Apr; 15(6):703-9. PubMed ID: 11371684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.
    Carr A; Miller J; Law M; Cooper DA
    AIDS; 2000 Feb; 14(3):F25-32. PubMed ID: 10716495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
    Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body composition in HIV-infected patients receiving highly active antiretroviral therapy.
    Chițu-Tișu CE; Barbu EC; Lazăr M; Bojincă M; Tudor AM; Hristea A; Abagiu AO; Ion DA; Bădărău AI
    Acta Clin Belg; 2017 Feb; 72(1):55-62. PubMed ID: 27724840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.
    Madeddu G; Spanu A; Solinas P; Babudieri S; Calia GM; Lovigu C; Mannazzu M; Nuvoli S; Piras B; Bagella P; Mura MS; Madeddu G
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4576-89. PubMed ID: 26698255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
    AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.
    Carr A; Workman C; Smith DE; Hoy J; Hudson J; Doong N; Martin A; Amin J; Freund J; Law M; Cooper DA;
    JAMA; 2002 Jul; 288(2):207-15. PubMed ID: 12095385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.
    Krikke M; Klomberg RCW; van der Veer E; Tesselaar K; Verhaar HJJ; Hoepelman AIM; Arends JE
    Neth J Med; 2017 May; 75(4):138-144. PubMed ID: 28522769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial abnormalities in HIV-infected lipoatrophic patients treated with antiretroviral agents.
    Chapplain JM; Beillot J; Begue JM; Souala F; Bouvier C; Arvieux C; Tattevin P; Dupont M; Chapon F; Duvauferrier R; Hespel JP; Rochcongar P; Michelet C
    J Acquir Immune Defic Syndr; 2004 Dec; 37(4):1477-88. PubMed ID: 15602126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients.
    Fernández-Rivera J; García R; Lozano F; Macías J; García-García JA; Mira JA; Corzo JE; Gómez-Mateos J; Rueda A; Sánchez-Burson J; Pineda JA
    HIV Clin Trials; 2003; 4(5):337-46. PubMed ID: 14583850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational study.
    Guaraldi G; Zona S; Orlando G; Carli F; Stentarelli C; Luzi K; Garlassi E; Menozzi M; Bagni P; Adorni F
    Clin Drug Investig; 2011 Nov; 31(11):759-67. PubMed ID: 21919542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.
    Teichmann J; Stephan E; Lange U; Discher T; Friese G; Lohmeyer J; Stracke H; Bretzel RG
    J Infect; 2003 May; 46(4):221-7. PubMed ID: 12799147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
    Calza L; Manfredi R; Chiodo F
    Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body composition changes in protease inhibitor-naive HIV-infected patients treated with two nucleoside reverse transcriptase inhibitors.
    Tsekes G; Chrysos G; Douskas G; Paraskeva D; Mangafas N; Giannakopoulos D; Papanikolaou M; Georgiou E; Lazanas MC
    HIV Med; 2002 Apr; 3(2):85-90. PubMed ID: 12010354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for the HIV-associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment.
    Mauss S; Corzillius M; Wolf E; Schwenk A; Adam A; Jaeger H; Knechten H; Goelz J; Goetzenich A;
    HIV Med; 2002 Jan; 3(1):49-55. PubMed ID: 12059951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study.
    Bonjoch A; Figueras M; Estany C; Perez-Alvarez N; Rosales J; del Rio L; di Gregorio S; Puig J; Gómez G; Clotet B; Negredo E;
    AIDS; 2010 Nov; 24(18):2827-33. PubMed ID: 21045635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.
    Miller J; Carr A; Emery S; Law M; Mallal S; Baker D; Smith D; Kaldor J; Cooper DA
    HIV Med; 2003 Jul; 4(3):293-301. PubMed ID: 12859330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.
    Bruera D; Luna N; David DO; Bergoglio LM; Zamudio J
    AIDS; 2003 Sep; 17(13):1917-23. PubMed ID: 12960824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+ -lymphocyte count and CD4+ -lymphocyte percentage at baseline and use of protease inhibitors and stavudine.
    Arpadi SM; Cuff PA; Horlick M; Wang J; Kotler DP
    J Acquir Immune Defic Syndr; 2001 May; 27(1):30-4. PubMed ID: 11404517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
    Boyd MA; Amin J; Mallon PW; Kumarasamy N; Lombaard J; Wood R; Chetchotisakd P; Phanuphak P; Mohapi L; Azwa I; Belloso WH; Molina JM; Hoy J; Moore CL; Emery S; Cooper DA;
    Lancet HIV; 2017 Jan; 4(1):e13-e20. PubMed ID: 27815068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.